Literature DB >> 19961860

Site-directed mutagenesis on human cystathionine-gamma-lyase reveals insights into the modulation of H2S production.

Shufen Huang1, Jia Hui Chua, Wen Shan Yew, J Sivaraman, Philip K Moore, Choon-Hong Tan, Lih-Wen Deng.   

Abstract

In recent years, increased interest has been directed towards hydrogen sulfide (H2S) as the third gasotransmitter and its role in various diseases. Cystathionine-gamma-lyase (CSE) is one of the enzymes responsible for the endogenous production of H2S in mammals. With the aid of the crystal structures of human CSE and site-directed mutagenesis studies, we have identified several amino acid residues in CSE that are actively involved in the catalysis of H2S production. Contrary to reports suggesting that Tyr114 is required for substrate binding, our results reveal a significant increase in the production of H2S upon mutation of Tyr114 to phenylalanine. This is attributed to an increased rate of pyridoxal 5'-phosphate (PLP) regeneration due to weakened pi-stacking interactions between Phe114 and PLP. Thr189 is also identified as a crucial residue where hydrogen bonding to Asp187 keeps the latter in an optimal position for hydrogen bonding to the pyridoxal nitrogen of PLP. Furthermore, mutation of Glu339 to lysine, alanine or tyrosine reveals the importance of the hydrophobicity of the 339th amino acid in determining the specificity of the enzyme for the catalysis of alpha,gamma-elimination or alpha,beta-elimination reaction. Our study also shows that the rate of H2S production is increased with increasing exogenous PLP concentration, hence supporting our hypothesis that apo-CSE is formed during the catalysis of H2S production. Taken together, these findings suggest novel routes towards the design of activators or inhibitors that modulate the production of H2S; these modulators may also serve as lead compounds in the development of drugs or mechanistic probes in the study of various H2S-related diseases. Copyright (c) 2009. Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19961860     DOI: 10.1016/j.jmb.2009.11.058

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  17 in total

Review 1.  PLP-dependent H(2)S biogenesis.

Authors:  Sangita Singh; Ruma Banerjee
Journal:  Biochim Biophys Acta       Date:  2011-02-17

2.  MPST but not CSE is the primary regulator of hydrogen sulfide production and function in the coronary artery.

Authors:  Maggie M Kuo; Dae Hee Kim; Sandeep Jandu; Yehudit Bergman; Siqi Tan; Huilei Wang; Deepesh R Pandey; Theodore P Abraham; Artin A Shoukas; Dan E Berkowitz; Lakshmi Santhanam
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-10-30       Impact factor: 4.733

3.  Metabolomic Evaluation of the Consequences of Plasma Cystathionine Elevation in Adults with Stable Angina Pectoris.

Authors:  Barbara N DeRatt; Maria A Ralat; Vegard Lysne; Fariba Tayyari; Indu Dhar; Arthur S Edison; Timothy J Garrett; Øivind Midttun; Per Magne Ueland; Ottar Kjell Nygård; Jesse F Gregory
Journal:  J Nutr       Date:  2017-08-09       Impact factor: 4.798

Review 4.  Chemical Biology of H2S Signaling through Persulfidation.

Authors:  Milos R Filipovic; Jasmina Zivanovic; Beatriz Alvarez; Ruma Banerjee
Journal:  Chem Rev       Date:  2017-11-07       Impact factor: 60.622

5.  De novo engineering of a human cystathionine-γ-lyase for systemic (L)-Methionine depletion cancer therapy.

Authors:  Everett Stone; Olga Paley; Jian Hu; Barbara Ekerdt; Nai-Kong Cheung; George Georgiou
Journal:  ACS Chem Biol       Date:  2012-09-21       Impact factor: 5.100

6.  Synthesis and biological activity of NOSH-naproxen (AVT-219) and NOSH-sulindac (AVT-18A) as potent anti-inflammatory agents with chemotherapeutic potential.

Authors:  Ravinder Kodela; Mitali Chattopadhyay; Khosrow Kashfi
Journal:  Medchemcomm       Date:  2013       Impact factor: 3.597

7.  The slow-releasing hydrogen sulfide donor, GYY4137, exhibits novel anti-cancer effects in vitro and in vivo.

Authors:  Zheng Wei Lee; Jianbiao Zhou; Chien-Shing Chen; Yujun Zhao; Choon-Hong Tan; Ling Li; Philip Keith Moore; Lih-Wen Deng
Journal:  PLoS One       Date:  2011-06-20       Impact factor: 3.240

8.  Fragment-based de novo design of a cystathionine γ-lyase selective inhibitor blocking hydrogen sulfide production.

Authors:  Angela Corvino; Beatrice Severino; Ferdinando Fiorino; Francesco Frecentese; Elisa Magli; Elisa Perissutti; Vincenzo Santagada; Mariarosaria Bucci; Giuseppe Cirino; Geoff Kelly; Luigi Servillo; Grzegorz Popowicz; Annalisa Pastore; Giuseppe Caliendo
Journal:  Sci Rep       Date:  2016-10-06       Impact factor: 4.379

9.  Selectivity of commonly used pharmacological inhibitors for cystathionine β synthase (CBS) and cystathionine γ lyase (CSE).

Authors:  Antonia Asimakopoulou; Panagiotis Panopoulos; Christos T Chasapis; Ciro Coletta; Zongmin Zhou; Giuseppe Cirino; Athanassios Giannis; Csaba Szabo; Georgios A Spyroulias; Andreas Papapetropoulos
Journal:  Br J Pharmacol       Date:  2013-06       Impact factor: 8.739

10.  Gastrointestinal safety, chemotherapeutic potential, and classic pharmacological profile of NOSH-naproxen (AVT-219) a dual NO- and H2S-releasing hybrid.

Authors:  Mitali Chattopadhyay; Ravinder Kodela; Pascale L Duvalsaint; Khosrow Kashfi
Journal:  Pharmacol Res Perspect       Date:  2016-03-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.